News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/April-2018/Volkmann_Elizabeth_LA_web.jpg)
No link seen between methotrexate, interstitial lung disease in RA
- Author:
- Susan London
Patients with RA had roughly three to five times the risk of interstitial lung disease, compared with the general population, but use of this...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Lindstrom_Ulf_web.jpg)
Some biologics may be better than others for averting anterior uveitis
- Author:
- Susan London
A Swedish cohort study of more than 3,500 patients with ankylosing spondylitis or undifferentiated spondyloarthritis finds that, relative to other...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Image/October-2018/Merkel_Peter_A_Philly_web.jpg)
Avacopan notches a win in ANCA-associated vasculitis
- Author:
- Susan London
The pivotal ADVOCATE trial showed that, relative to prednisone, the oral C5a receptor antagonist yielded a superior rate of sustained remission at...
News
Blood test might detect multiple cancer types, study suggests
- Author:
- Susan London
The test, which uses methylation patterns in plasma cell-free DNA, had specificity and sensitivity approaching those needed for population-based...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Giulia_Grande_Sweden_web.jpg)
Cardiovascular disease is implicated in link between air pollution and dementia
- Author:
- Susan London
The Swedish SNAC-K study of nearly 3,000 older adults suggests that heart failure and ischemic heart disease enhance the deleterious effect of air...
News
CLEOPATRA: Pertuzumab has long-term benefit in HER2+ breast cancer
- Author:
- Susan London
Adding pertuzumab to trastuzumab and docetaxel as first-line therapy for metastatic HER2-positive breast cancer reduced the risk of death by 31%...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/herpes_zoster_shingles_web_0_0.jpg)
Live zoster vaccine confers limited protection during tofacitinib therapy
- Author:
- Susan London
Five percent of patients with rheumatoid arthritis given the live attenuated zoster vaccine before starting tofacitinib still developed shingles...
News
Teledermoscopy using smartphones fails to boost skin cancer detection
- Author:
- Susan London
Mobile teledermoscopy did not increase the sensitivity of skin cancer detection, compared with naked-eye skin...
News
Vision symptoms are common and often life-altering for patients with Parkinson’s disease
- Author:
- Susan London
Two-thirds of patients reported ophthalmologic problems that were severe enough to interfere with activities such as walking, reading, working on...
News
Adjuvant chemo emerges as new standard in upper tract urothelial cancer
- Author:
- Susan London
The POUT trial suggests platinum-based chemotherapy is safe and effective in this rare disease that lacks international consensus on postsurgical...
News
Adjunctive surgery may be unnecessary in many testicular cancer patients
- Author:
- Susan London
SAN FRANCISCO – Adjunctive resection of organs, blood vessels, or bone was deemed unnecessary in almost 40% of testicular cancer patients analyzed...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/145042_Boorjian_Stephen_A_web.jpg)
Gene therapy appears effective in bladder cancer patients with few options
- Author:
- Susan London
SAN FRANCISCO – Intravesical gene therapy produced durable responses in patients with non–muscle invasive bladder cancer that did not respond to...
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Apalutamide benefit sustained in mCSPC regardless of next therapy
- Author:
- Susan London
SAN FRANCISCO – The risk of second progression-free survival events was about one-third lower for patients who initially received apalutamide...
News
![](https://www.qa.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Seminoma: Risk-adapted strategy could mean less toxic chemo
- Author:
- Susan London
SAN FRANCISCO – Findings of the SEMITEP trial suggest that early FDG-PET identifies the two-thirds of men with highly chemosensitive low-volume...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/144949_Hammers_Hans_web.jpg)
SBRT may boost efficacy of immunotherapy in renal cell carcinoma
- Author:
- Susan London
SAN FRANCISCO – More than half of patients in the RADVAX RCC trial had a response in nonirradiated lesions, but the prespecified threshold for...